This series is organised by E4H, in partnership with the Academic Health Science Network, London Clinical Network, voluntary sector and NHS England.
Supported by Bayer, Daiichi-Sankyo, and Pfizer Limited on behalf of the BMS-Pfizer Alliance.

Cambridge

Thursday 7 February 2019
Møller Centre

AGENDA

09:30 AM

Registration & Refreshments

09:55 AM

Event App Overview Karl Hamer

10:00 AM

Welcome Piers Ricketts

10:10 AM

AF - The Challenge We Face Helen Williams

10:25 AM

National AHSN Programme Faye Edwards

We will explore the scale of opportunities and challenges ahead. Look at national initiatives and their impact to-date.

10:40 AM

Eastern AHSN Approach Dr Amanda Buttery

11:00 AM

SOS-AF Service: Implementation of a secondary care service for screening, optimisation and support for stroke prevention Dr Kayvan Khadjooi

11:30 AM

Panel Q&A Session 

11:45 AM

Morning Refreshments

12:00 AM

Roundtable Discussions (6 tables - choose 3) - 20 minutes each session

Delegate packs will be presented with personalised localised data. An action plan with detect/protect/perfect and recommendations on how each supporter can help you to achieve their AF acceleration objectives.

  • Anticoagulation – Myth Buster – Sotiris Antoniou
  • Detection in innovative settings – Alex Lang
  • Virtual Clinics in AF – Helen Williams
  • AF West Norfolk Clinic – Dr Raj Shekhar
  • NICE – Regional resources to support detection of AF and anticoagulation – Deborah O'Callaghan
  • AFA – TBC
13:00 PM

Lunch

14:00 PM

My AF Story Steve Cousins

14:10 PM

Initiating Anticoagulation in Primary Care Dr Sarah Flindall and Dr Kamal De

14:30 PM

Panel Q&A Session

14:40 PM

Afternoon Refreshments

15:00 PM

Roundtable Discussions

  • Anticoagulation – Myth Buster – Sotiris Antoniou
  • Detection in innovative settings – Alex Lang
  • Virtual Clinics in AF – Helen Williams
  • AF West Norfolk Clinic – Dr Raj Shekhar
  • NICE – Regional resources to support detection of AF and anticoagulation – Deborah O'Callaghan
  • AFA – TBC
16:00 PM

Why do we need trials of AF screening? Professor Jonathan Mant

16:25 PM

Evaluation and Close Piers Ricketts

SPEAKERS

Piers Ricketts became CEO of Eastern Academic Health Science Network (Eastern AHSN) in April 2018. Eastern AHSN is based in Cambridge with a remit to act as a networker, broker and change agent across the East of England for the adoption into the NHS of innovations coming out of clinical academia, MedTech, start-ups and the public and private sectors more generally. As part of his current role Piers is also the national AHSN lead for the MedTech sub-sector, identifying and promoting areas of particular growth.

Piers was previously a Partner at KPMG, where his leadership roles included running the healthcare management consulting practice and leading major transformation projects in higher education, social housing and the wider public sector. He therefore understands the challenges and solutions facing the wider public sector in an era of financial challenge alongside increasing public expectation. Piers is a Chartered Accountant and previously spent ten years in KPMG’s Transaction Services practice, supporting private and public sector clients in major commercial deals.

Jonathan Mant is professor of primary care research and head of the primary care unit in the Department of Public Health & Primary Care of the University of Cambridge. He is an honorary consultant for Public Health England and at Addenbrooke’s Hospital. He is an NIHR Senior Investigator and a Fellow of the Academy of Medical Sciences. He trained in public health medicine in the Oxford Region, and was clinical lecturer in public health medicine at the University of Oxford 1991-1997, before moving to the University of Birmingham as a senior lecturer in Primary Care Clinical Sciences in 1997. In 2008 he took up his chair in Cambridge. His research interests focus on the prevention and management of cardiovascular disease, particularly stroke, in community settings. He is currently leading programme grants funded by NIHR which aim to develop and evaluate primary care services for stroke and to evaluate whether screening for atrial fibrillation prevents stroke and saves lives.

Faye is the National Programme Manager for the Atrial Fibrillation (AF) Programme across the 15 Academic Health Science Networks, she oversees the AF programme across the three programme elements; Detect, Protect and Perfect. This includes the national roll out of AF detection devices, raising public awareness of AF, improving the quality of anticoagulation services and the spread and adoption of best practice in AF nationwide.

Sotiris is Consultant Pharmacist at Barts Heart Centre, part of Barts Health NHS Trust. Combined with his role as Lead Cardiovascular Pharmacist for UCL Partners supports medicines optimisation across the health economy to optimise patient outcomes and address unmet local needs.

He is an independent prescriber and is currently chair of the cardiac committee for United Kingdom Clinical Pharmacy Association (UKCPA). He is chair of the international Pharmacist Anticoagulation Taskforce (iPACT). An international group of over 20 countries aimed to improve pharmaceutical care around anticoagulants, by providing background materials and stimulating pharmacists to provide appropriate care to their patients. Sotiris is also a member of the Atrial Fibrillation Association medical advisory panel.

He has published extensively in the medical press and has a particular interest in in improving anticoagulation for stroke prevention in atrial fibrillation. Sotiris has been successful in obtaining a Lord Darzi funded fellow to ‘co-design and test a new referral pathway for people with atrial fibrillation with community pharmacists’ with the aim to support individuals understanding of their condition and their therapy with the ultimate aim of optimising adherence. Sotiris is also a member of the ‘AF-SCREEN International collaboration’ that produced a white paper titled ‘Screening for Atrial Fibrillation’. The AF-SCREEN international collaboration was formed in September 2015 to promote discussion and research about AF screening as a strategy to reduce stroke and death and to provide advocacy for implementation of country-specific AF screening programs.

He is actively involved in the training and development of clinical pharmacists including developing a curriculum and assessment tool for advanced and consultant level specialist cardiac pharmacists working with the UKCPA and Royal Pharmaceutical Society.

Sotiris has served on many NICE development groups including Unstable Angina/NSTEMI guideline, stable angina and STEMI guidelines and is a current NICE TA member of the highly specialist technology appraisal group. He is also a member of the London Strategic Clinical Network Cardiovascular Leadership Group and NHS England Medicines Optimisation Intelligence Group meeting. Sotiris is also an honorary senior research associate at UCL School of Pharmacy.

Consultant Pharmacist for Cardiovascular Disease, South London, UK
National Clinical Adviser for AF, AHSN Network
Clinical Director for AF, Health Innovation Network
Clinical Lead for Cardiovascular Disease, Southwark and Lambeth CCGs

As Consultant Pharmacist for CVD Disease, Helen is involved in a wide range of activities across South London to improve the care of patients with or at risk of cardiovascular disease (CVD). Helen chairs the local cardiovascular medicines working group which develops and supports the implementation of consensus evidence-based guidance for use across South London’s 12 clinical commissioning groups and 7 acute trusts, covering a population of 3.6million. Currently, there is a strong focus on medicines optimisation in primary care for long terms conditions such as heart failure, hypertension and atrial fibrillation with the aim of reducing the burden of acute hospital admissions and she has been involved in supporting primary care practitioners through guideline implementation, clinical audit and provision of pharmacist-led virtual clinics. A key focus over recent years has been to increase the proportion of patients with AF who are anticoagulated to reduce the incidence of AF-related stroke.

Helen is also the clinical lead for CVD within two South London CCGs, Clinical Director for AF in the local Health Innovation Network, National Clinical Adviser to the collaborative AF programme of the 15 Academic Health Science Networks across England and also co-chair of the Pan-London stroke prevention in Atrial Fibrillation strategy group. In addition, Helen is an editorial board member for the British Journal of Cardiology and the Journal of Medicines Optimisation, has worked with NICE on the development of a number of cardiovascular guidelines and is a member of the NHS England Primary Care Cardiovascular Leadership Forum and the London Cardiovascular and Stroke Strategic Clinical Leadership Groups.

Dr Kayvan Khadjooi  is a Consultant in Stroke Medicine at Addenbrooke’s Hospital and Associate Lecturer in University of Cambridge, School of Medicine. His special interests are stroke prevention in patients with atrial fibrillation, treatment of acute stroke, and Medical Education. He is the educational lead for telemedicine in acute stroke services in East of England and has set up a number of successful training courses, such as The Cambridge Thrombolysis in Acute Stroke Masterclass.

He is the founder and clinical lead for Stroke Prevention in Atrial Fibrillation service in Cambridge University Hospitals, which is one of the winners of the AF Association Healthcare Pioneers Award 2019.

Amanda Buttery BAppSci MSc PhD MCSP

Programme Manager Eastern ASHN

Honorary Clinical Lecturer King’s College London

Amanda Buttery is a clinical academic and specialises in health service innovation, implementation and evaluation on a wide range of topics related to older people. She leads the Eastern AHSN Atrial Fibrillation Programme. She has an MSc and PhD in Gerontology from King’s College London and has previously held positions as a Guest Scientist at the Robert Koch Institute in Germany and as an Innovation Fellow at the Health Innovation Network at Guy’s and St Thomas’ NHS Foundation Trust in London. Amanda is a current member of the East of England Cardiovascular Disease Prevention Programme Advisory Board and is on the Steering Committee of the National Audit of Dementia at the Royal College of Psychiatrists.

Since 2010 involved with local PPG. Have been PPG Ambassador for E&N Herts CCG to create more active groups. Diabetes UK trained facilitator for Type ll Together. Councillor with special responsibilities for Health and Wellbeing. Active member of EOE Citizens’ Senate and board member of EAHSN Digital Innovation Board.

Dr Flindall is a General Practitioner and partner at East Norfolk Medical Practice, where she is safeguarding lead, having trained and worked within practices across the locality. She has worked in Out of Hours and is an Associate Trainer. She is the Clinical Lead for the CVD/CHD RightCare Programme in Norfolk and Waveney Sustainability and Transformation Plan (STP). She is also a retained GP at Great Yarmouth and Waveney Clinical Commissioning Group (GYWCCG).

She has many years of experience in working on improvement projects in the community within the Children’s, Young People and Maternity services. She offers clinical representation to the Learning from Deaths Community of Practice. Sarah is an Honorary Senior Lecturer at The University of East Anglia, involved in teaching Year 5 Medical Students, having previously taught year 4 and been involved with years 3 and 1. She was a Local Medical Committee (LMC) representative for Great Yarmouth and Waveney for the last 3 years. She has a role within the NHS Revalidation system as an appraiser.

Dr Kamal De  MBBS  FRCP (Lond)  Diploma Cardiology ( Middlesex University)

Dr Kamal De is a General Practitioner and partner at Vida Healthcare based in King’s Lynn, Norfolk. As cardiovascular lead at his practice he has particular   interest in improving the management of hypertension, atrial fibrillation and heart failure within community settings across his locality. He has had previous experience in successfully developing community heart failure clinics and his current focus has been on the deployment of an atrial fibrillation pilot in the West Norfolk region.

Dr De currently supervises the training of FY2 doctors and GP registrars in primary care settings. As an experienced teacher-practitioner, he plays an active part in the education of Year 5 medical students and is an OSCE examiner for final year medical students at the University of Cambridge. He previously held such a position at The University of East Anglia Medical School.

Raj Shekhar MBBS, MD, FRCP

Dr Shekhar is lead stroke consultant at the Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust. He joined this Trust in 2008 following completion of his higher specialist training in Cardiff and Stroke Sub-specialist training at St Georges Hospital London. Under his innovative and skilled leadership stroke services were established for West Norfolk and the Trust.  Since then, he has managed to sustain a nationally recognized consistently well performing comprehensive stroke services. Following pilot of Telemedicine stroke services for the East of England, he has taken the responsibilities of medical lead and successfully maintained this service to provide out of hours stroke thrombolysis services for a number of hospitals in this region. Dr Shekhar is a principal investigator for stroke research at the hospital. He is keen to improve acute stroke care and stroke prevention services including TIA and AF.

Recently, he has taken clinical managerial responsibilities and following clinical director role for four years, now he has taken the role of Associate Medical Director for the Medicine Directorate. Under his leadership he aspires to achieve functional seven days service as well as early clinical decision making to improve health outcomes.

He is a keen educator and enjoys teaching medical students from UEA and Cambridge medical schools, junior and senior medical trainees as well as stroke MDT. He is OSCE examiner for UEA medical school, MRCP PACES examiner for the Royal College of Physicians, London and is member of panel for Fitness to Practice pilot and OSCE for the General Medical Council, UK.

VENUE

Moller cambridge 600

Møller Centre

Churchill College Storey’s Way, Cambridge CB3 0DE (SAT NAV use CB3 0DS)

Car:
There is free on-site parking for over 150 cars at the Møller Centre. Please note when entering Storey’s Way from Huntingdon Road (A1307), there are width restrictions. Alternatively approach Storey’s Way from the Madingley Road entrance. If you are using a Sat Nav please use the postcode CB3 0DS.

Train:
There is a fast and frequent rail service from London King’s Cross (45 minutes) & London Liverpool Street (1 hour 15 mins) and Stansted Airport (30 minutes) through to Cambridge. There are excellent connections from Scotland & the North via Peterborough, as well as services from Birmingham & the Midlands, East Anglia & the North West. Cambridge train station is about a 20 minute taxi ride from the Møller Centre. Cambridge North train station is also about 20 minutes drive away from the Centre.

Bus: Information on bus services in Cambridge can be found on the Cambridge City Council website.

Cycle: The centre is a 5 minute cycle from the city centre. There is plenty of cycle parking.

FREE REGISTRATION

Registration is free for healthcare professionals within the UK who have a special interest in AF. Please note that spaces are limited and available on a first-come first-served basis.

LOCAL ACADEMIC HEALTH SCIENCE NETWORK

aster-ahsn